Right the First Time: How a Minneapolis Company Uses DNA Test to Limit the Side Effects of Psychiatric Meds

MinnPost published an article recounting the story of how OneOme’s RightMed pharmacogenomic test helped identify an effective prescription treatment for a teenager struggling with mental health conditions.

For 10 years Carly and her family searched for the right medications and doses for her anxiety, ADHD, and depression. This process caused adverse drug reactions that had mentally and physically debilitating effects on Carly’s childhood.

When she was 17 years old, her family found out about the OneOme RightMed pharmacogenomic test, which uses a patient’s DNA to provide insight into how he/she may respond to certain drugs. When they received Carly’s RightMed test report, her physician adjusted her prescription, and the results were life changing. After 10 years of trial and error, they finally found the prescription that worked for her.

Read the MinnPost article, Right the first time: How a Minneapolis company uses DNA tests to limit the side effects of psychiatric meds.